Charter Oak Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,926
Closed -$272K 215
2025
Q4
$272K Buy
10,926
+922
+9% +$23.3K 0.02% 177
2025
Q3
$255K Sell
10,004
-659
-6% -$16.3K 0.02% 180
2025
Q2
$258K Buy
10,663
+444
+4% +$10.4K 0.02% 176
2025
Q1
$259K Sell
10,219
-851
-8% -$22.3K 0.02% 169
2024
Q4
$294K Sell
11,070
-178
-2% -$4.83K 0.03% 146
2024
Q3
$326K Sell
11,248
-463
-4% -$13.5K 0.03% 142
2024
Q2
$328K Sell
11,711
-744
-6% -$20.5K 0.03% 134
2024
Q1
$346K Sell
12,455
-50
-0.4% -$1.39K 0.04% 135
2023
Q4
$360K Buy
12,505
+1,011
+9% +$30.6K 0.04% 126
2023
Q3
$381K Sell
11,494
-155
-1% -$5.48K 0.05% 119
2023
Q2
$427K Buy
11,649
+647
+6% +$25.2K 0.06% 116
2023
Q1
$449K Buy
11,002
+824
+8% +$35.6K 0.06% 111
2022
Q4
$522K Sell
10,178
-477
-4% -$22.9K 0.08% 95
2022
Q3
$466K Sell
10,655
-7
-0.1% -$340 0.07% 100
2022
Q2
$559K Sell
10,662
-535
-5% -$27.3K 0.08% 101
2022
Q1
$580K Buy
11,197
+13
+0.1% +$675 0.07% 110
2021
Q4
$660K Buy
11,184
+17
+0.2% +$842 0.08% 103
2021
Q3
$480K Buy
11,167
+3,185
+40% +$141K 0.06% 112
2021
Q2
$313K Buy
7,982
+72
+0.9% +$2.8K 0.04% 137
2021
Q1
$287K Buy
7,910
+50
+0.6% +$1.77K 0.04% 141
2020
Q4
$289K Buy
+7,860
New +$288K 0.04% 137

Other funds holding PFE

Charter Oak Capital Management's PFE Position: Q1 2026 in Review

Charter Oak Capital Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 10,926 shares — an estimated $272K sold.

Charter Oak Capital Management first reported a position in PFE in Q4 2020 and held it in 21 quarters. The position peaked at $660K in Q4 2021. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Charter Oak Capital Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Charter Oak Capital Management sold 10,926 Pfizer shares in Q1 2026, an estimated $272K.
  • Charter Oak Capital Management first reported a position in Pfizer in Q4 2020 and held it in 21 quarters.
  • Charter Oak Capital Management's Pfizer position peaked at $660K in Q4 2021.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Charter Oak Capital Management's 13F filing for Q1 2026, filed 24 Apr 2026.